Search hospitals > Minnesota > Saint Paul
Minnesota Oncology Hematology PA-Maplewood
Claim this profileSaint Paul, Minnesota 55109
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Recurrence
Conducts research for Adenocarcinoma
475 reported clinical trials
13 medical researchers
Summary
Minnesota Oncology Hematology PA-Maplewood is a medical facility located in Saint Paul, Minnesota. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Recurrence, Adenocarcinoma and other specialties. Minnesota Oncology Hematology PA-Maplewood is involved with conducting 475 clinical trials across 512 conditions. There are 13 research doctors associated with this hospital, such as David M. King, Daniel M. Anderson, Yan Ji, and Pamala A. Pawloski.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Breast Cancer
Global LeaderHER2 negative
ER positive
Stage IV
Top PIs
David M. KingPark Nicollet Clinic - Saint Louis Park7 years of reported clinical research
Expert in Cancer
Expert in Lung Cancer
97 reported clinical trials
159 drugs studied
Daniel M. AndersonRegions Hospital4 years of reported clinical research
Expert in Cancer
Expert in Tumors
60 reported clinical trials
108 drugs studied
Yan JiRegions Hospital1 year of reported clinical research
Expert in Cancer
Studies Breast Cancer
30 reported clinical trials
74 drugs studied
Pamala A. PawloskiPark Nicollet Clinic - Saint Louis Park5 years of reported clinical research
Studies Cancer
Studies Tumors
14 reported clinical trials
19 drugs studied
Clinical Trials running at Minnesota Oncology Hematology PA-Maplewood
Breast Cancer
Esophageal Adenocarcinoma
Gastroesophageal Junction Adenocarcinoma
Cancer
Esophageal Carcinoma
Non-Small Cell Lung Cancer
Bladder Cancer
Lung Cancer
Prostate Cancer
Gastric Cancer
Shorter Chemo-Immunotherapy Without Anthracyclines
for Breast Cancer
This phase III trial compares the effects of shorter chemotherapy (chemo)-immunotherapy without anthracyclines to usual chemo-immunotherapy for the treatment of early-stage triple negative breast cancer. Paclitaxel is in a class of medications called anti-microtubule agents. It stops cancer cells from growing and dividing and may kill them. Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of cancer cells. Cyclophosphamide is in a class of medications called alkylating agents. It works by damaging the cell's deoxyribonucleic acid (DNA) and may kill cancer cells. It may also lower the body's immune response. Docetaxel is in a class of medications called taxanes. It stops cancer cells from growing and dividing and may kill them. Doxorubicin is an anthracycline chemotherapy drug that damages DNA and may kill cancer cells. Pembrolizumab may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Shorter treatment without anthracycline chemotherapy may work the same as the usual anthracycline chemotherapy treatment for early-stage triple negative breast cancer.
Recruiting2 awards Phase 347 criteria
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Carvedilol
for Preventing Heart Problems in HER2 Positive Breast Cancer
This phase III trial studies how well carvedilol works in preventing cardiac toxicity in patients with human epidermal growth factor receptor (HER)-2-positive breast cancer that has spread to other places in the body. A beta-blocker, such as carvedilol, is used to treat heart failure and high blood pressure, and it may prevent the heart from side effects of chemotherapy.
Recruiting2 awards Phase 323 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Minnesota Oncology Hematology PA-Maplewood?
Minnesota Oncology Hematology PA-Maplewood is a medical facility located in Saint Paul, Minnesota. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Recurrence, Adenocarcinoma and other specialties. Minnesota Oncology Hematology PA-Maplewood is involved with conducting 475 clinical trials across 512 conditions. There are 13 research doctors associated with this hospital, such as David M. King, Daniel M. Anderson, Yan Ji, and Pamala A. Pawloski.
Where is Minnesota Oncology Hematology PA-Maplewood located?
**Minnesota Oncology Hematology PA-Maplewood**
- **Address:** 310 Smith Ave N, Suite 100, Saint Paul, MN 55102
- **Directions:** Take I-94 E to exit 238B for US-10 E towards Maplewood. Continue on US-10 E to Smith Ave N.
Who should I call to ask about financial aid or insurance network?
**Minnesota Oncology Hematology PA-Maplewood Financial and Insurance Assistance:**
- **Financial Assistance:** Contact the Patient Benefit Representative at your clinic or call (844) 317-4673 for help with insurance claims and finding financial assistance through nationally recognized programs.
- **Insurance Inquiries:** Call (844) 317-4673 for assistance with insurance-related questions. Minnesota Oncology submits claims to most major insurance carriers on your behalf.
- **Pharmacy Inquiries:** For assistance with medications, pain management, and drug interactions, contact the Maplewood Cancer Center pharmacist at (651) 255-8480. They also help with insurance approval and obtaining financial assistance.
What insurance does Minnesota Oncology Hematology PA-Maplewood accept?
Minnesota Oncology Hematology PA-Maplewood accepts a wide range of insurance plans, including Aetna, Medicare, PPO, CMS, BCBS Blue Card, Cigna, Anthem, First Health, Wellmark, UHC Community & State - Direct, and Medica. They participate in value-based payment models with Blue Cross Blue Shield of Minnesota to deliver best-in-class results at a lower overall cost.
What awards or recognition has Minnesota Oncology Hematology PA-Maplewood received?
Minnesota Oncology Hematology PA-Maplewood, located in Saint Paul, Minnesota, is the Twin Cities' largest and most experienced cancer treatment provider. It has been designated as a Blue Distinction® Center for Cancer Care by Blue Cross Blue Shield Minnesota, highlighting its commitment to delivering high-quality, cost-effective cancer care.